English
German
Spanish
Italian
Japanese
United states
VIOLETTE Trial Shows Precise Planning in Prostate Cancer Microwave Ablation
Investigators of the multicentric, phase 2 VIOLETTE trial (NCT04582656) evaluating the use of organ-based tracking fusion (OBT-Fusion) technology in focal ablation of the prostate by microwave needles has finalized enrollment and published interim results, Koelis, the developer, announced in a press release.
The trial utilized the Koelis Trinity® fusion imaging system, which employs OBT-Fusion technology to visualize and create a 3D map of the prostate while recording identified lesions. Investigators are evaluating the modality’s use through targeted microwave ablation.
